ASMIDINE treatment for control of asthma symptoms

Overview

Asmidine is a novel polymeric asthma prevention treatment designed to control and prevent asthma exacerbations. It is a nasal spray that creates a protective surface film on the nasal mucosa, offering a safe and effective alternative to chemical drugs for asthma treatment.

Mechanism of Action

Asmidine works by protecting, cleaning, and removing inflammatory cytokines from the nasal mucosa. This process reduces inflammation and helps prevent asthma attacks.

Asmidine is a nasal spray that forms a protective surface film on the nasal mucosa. This film is created by a solution of glycerol associated with jellifying agents and specific dual-acting polymeric extracts. These polymers have an affinity for glycerol molecules and also bind with specific proteins, including key asthma disease-specific pro-inflammatory cytokines such as TSLP, IL-25, and IL-33.

By trapping these pro-inflammatory cytokines, Asmidine reduces inflammation in the nasal mucosa, which helps prevent asthma attacks. This unique mechanism of action offers a new approach to asthma prevention and control, providing a safe and effective alternative to traditional asthma treatments.

Clinical Efficacy

Adults : Asmidin vs Salbutamol

In clinical trials, Asmidine has shown significant improvements in lung function and overall quality of life for adult patients. It effectively controls bronchial asthma without any reported adverse effects.

See full publication (PDF)

Children

Asmidine has also been tested in children, where it has shown to increase lung function, improve quality of life, and reduce the need for additional medication. It has been found to be safe and effective, with no adverse effects reported.

See full publication (PDF)

Asmidine offers a new approach to asthma prevention and control. Its unique mechanism of action and proven clinical efficacy make it a promising alternative to traditional asthma treatments.

In conclusion, the clinical trials conducted on Asmidine have demonstrated promising results in both adult and pediatric populations. The trials showed that Asmidine significantly improved lung function and overall quality of life, effectively controlling bronchial asthma without any reported adverse effects.

Importantly, Asmidine demonstrated an efficacy similar to that of Salbutamol, a commonly used asthma medication. This is particularly noteworthy given that Asmidine operates through a unique mechanism of action, offering a new approach to asthma prevention and control.

These results suggest that Asmidine could be a safe and effective alternative to traditional chemical drugs for asthma treatment, providing a new option for patients who may not respond well to current treatments or who may be seeking a non-chemical approach to managing their asthma.